Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Even as new technologies transform healthcare, local leaders emphasized the importance of never losing the human touch within ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

An open-minded rethinking of how the 12,500-seat Coliseum might be renovated, promoted, managed and financed could make the ...

For four decades, the USA has officially celebrated Black History Month, but efforts to honor African American history in ...

Marty Ochs, executive director of GBIG, called the expo the first event of its kind to focus on packaging, printing, paper, ...

Kilroy Realty has opened a second phase of its Oyster Point life sciences campus — but it's attracting financial and tech ...

VANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), a biotechnology company ...

VIV Asia 2025, the region’s most comprehensive feed-to-food exhibition, is set to lead the conversation once more on the ...

As an innovator and pioneer of the global bio-manufacturing industry, Cathay Biotech takes technological innovation as its core competence and continues to invest heavily in R&D. The continuous ...